Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Ann M. Vanrolleghem"'
Autor:
Nikki van Leeuwen, Hester F Lingsma, Ann M Vanrolleghem, Miriam C J M Sturkenboom, Pieter A van Doorn, Ewout W Steyerberg, Bart C Jacobs
Publikováno v:
PLoS ONE, Vol 11, Iss 2, p e0143837 (2016)
BACKGROUND:Guillain-Barré syndrome (GBS) has a highly variable clinical course, leading to frequent transfers within and between hospitals and high associated costs. We defined the current admissions, transfers and costs in relation to disease sever
Externí odkaz:
https://doaj.org/article/6f443577f97c49b6b71b247dfb274ec8
Autor:
Karin Hek, Peter A. G. M. De Smet, Mees Mosseveld, Fouzia Lghoul-Oulad Said, Margaretha F. Warlé-van Herwaarden, Patricia M. L. A. van den Bemt, Ron M. C. Herings, Sandra de Bie, L. Flinterman, Bruno H. Ch. Stricker, Miriam C. J. M. Sturkenboom, Vera E. Valkhoff, Jelmer Alsma, Ann M. Vanrolleghem
Publikováno v:
Pharmacoepidemiology and Drug Safety
Lghoul-Oulad Saïd, F, Hek, K, Flinterman, L E, Herings, R M, Warlé-van Herwaarden, M F, de Bie, S, Valkhoff, V E, Alsma, J, Mosseveld, M, Vanrolleghem, A M, Stricker, B H, Sturkenboom, M C, De Smet, P A & van den Bemt, P M 2020, ' Prevalence and incidence rate of hospital admissions related to medication between 2008 and 2013 in The Netherlands ', Pharmacoepidemiology and Drug Safety, vol. 29, no. 12, pp. 1659-1668 . https://doi.org/10.1002/pds.5122
Pharmacoepidemiology and Drug Safety, 29(12), 1659-1668. John Wiley and Sons Ltd
Pharmacoepidemiology and Drug Safety, 1659-1668. Wiley
ISSUE=12;STARTPAGE=1659;ENDPAGE=1668;ISSN=1053-8569;TITLE=Pharmacoepidemiology and Drug Safety
Pharmacoepidemiology and Drug Safety, 29(12), 1659-1668. John Wiley & Sons Ltd.
Lghoul-Oulad Saïd, F, Hek, K, Flinterman, L E, Herings, R M, Warlé-van Herwaarden, M F, de Bie, S, Valkhoff, V E, Alsma, J, Mosseveld, M, Vanrolleghem, A M, Stricker, B H, Sturkenboom, M C, De Smet, P A & van den Bemt, P M 2020, ' Prevalence and incidence rate of hospital admissions related to medication between 2008 and 2013 in The Netherlands ', Pharmacoepidemiology and Drug Safety, vol. 29, no. 12, pp. 1659-1668 . https://doi.org/10.1002/pds.5122
Pharmacoepidemiology and Drug Safety, 29(12), 1659-1668. John Wiley and Sons Ltd
Pharmacoepidemiology and Drug Safety, 1659-1668. Wiley
ISSUE=12;STARTPAGE=1659;ENDPAGE=1668;ISSN=1053-8569;TITLE=Pharmacoepidemiology and Drug Safety
Pharmacoepidemiology and Drug Safety, 29(12), 1659-1668. John Wiley & Sons Ltd.
PURPOSE: In 2009 a Dutch guideline was published containing recommendations to reduce Hospital Admissions Related to Medications (HARMs). This study aims to examine time-trends of HARMs and their potential preventability between 2008 and 2013 in The
Autor:
Patricia E Vermeer-de Bondt, Teske Schoffelen, Ann M Vanrolleghem, Leslie D Isken, Marcel van Deuren, Miriam C J M Sturkenboom, Aura Timen
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0123570 (2015)
In 2011, a unique Q fever vaccination campaign targeted people at risk for chronic Q fever in the southeast of the Netherlands. General practitioners referred patients with defined cardiovascular risk-conditions (age >15 years). Prevalence rates of t
Externí odkaz:
https://doaj.org/article/f5eb9779d37c4fc89e6b567d690237e7
Autor:
J. A. van Vliet, T. M. Schurink-van’t Klooster, M. Ter Wolbeek, N.A.T. van der Maas, E M van de Putte, Ann M. Vanrolleghem, Sanne L. Nijhof, H.E. de Melker, Miriam C. J. M. Sturkenboom, J.M. Kemmeren
Publikováno v:
Vaccine, 36(45), 6796. Elsevier BV
Vaccine, 36(45), 6796-6802. Elsevier
Vaccine, 36(45), 6796-6802. Elsevier
Introduction In 2013, the Netherlands Pharmacovigilance Center Lareb published an overview of reports of long-lasting fatigue following bivalent HPV-vaccination (2vHPV). After an update of this overview in 2015, concerns regarding the safety of 2vHPV
Autor:
Maria A. J. de Ridder, Ivo K Joore, Suzanne E. Geerlings, Jan E. A. M. van Bergen, Denise E Twisk, Ann M. Vanrolleghem, Ingrid V F van den Broek
Publikováno v:
BMC family practice, 17(1). BioMed Central
BMC Family Practice
BMC Family Practice, 17:161. BioMed Central Ltd.
BMC Family Practice
BMC Family Practice, 17:161. BioMed Central Ltd.
Background European guidelines recommend offering an HIV test to individuals who display HIV indicator conditions (ICs). We aimed to investigate the incidence of ICs in primary care reported in medical records prior to HIV diagnosis. Methods We did a
Autor:
Ann M. Vanrolleghem, Miriam C. J. M. Sturkenboom, Pieter A. van Doorn, Hester F. Lingsma, Nikki van Leeuwen, Bart C. Jacobs, Ewout W. Steyerberg
Publikováno v:
PLoS ONE
PLoS One (print), 11(2). Public Library of Science
PLoS ONE, Vol 11, Iss 2, p e0143837 (2016)
PLoS One (print), 11(2). Public Library of Science
PLoS ONE, Vol 11, Iss 2, p e0143837 (2016)
textabstractBackground Guillain-Barre syndrome (GBS) has a highly variable clinical course, leading to frequent transfers within and between hospitals and high associated costs. We defined the current admissions, transfers and costs in relation to di
Autor:
Eva M. van Soest, Miriam C. J. M. Sturkenboom, Jeanne P. Dieleman, Katia M.C. Verhamme, Ann M. Vanrolleghem, Gaganpreet Kaur, Bruno H. Ch. Stricker
Publikováno v:
Journal of Clinical Periodontology. 37:625-630
Kaur G, Verhamme KMC, Dieleman JP, Vanrolleghem A, van Soest EM, Stricker BHCh, Sturkenboom MCJM. Association between calcium channel blockers and gingival hyperplasia. J Clin Periodontol 2010; 37: 625–630. doi: 10.1111/j.1600-051X.2010.01574.x. Ab
Autor:
Leslie D. Isken, Patricia E. Vermeer-de Bondt, Teske Schoffelen, Miriam C. J. M. Sturkenboom, Aura Timen, Ann M. Vanrolleghem, Marcel van Deuren
Publikováno v:
PLoS ONE
PLoS One, 10, 4
PLoS ONE, Vol 10, Iss 4, p e0123570 (2015)
PLoS One (print), 10(4). Public Library of Science
PLoS One, 10
PLoS One, 10, 4
PLoS ONE, Vol 10, Iss 4, p e0123570 (2015)
PLoS One (print), 10(4). Public Library of Science
PLoS One, 10
Contains fulltext : 154899.PDF (Publisher’s version ) (Open Access) BACKGROUND: In 2011, a unique Q fever vaccination campaign targeted people at risk for chronic Q fever in the southeast of the Netherlands. General practitioners referred patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::305f8163e36e9efcd7ff32cf6a01d796
https://doi.org/10.1371/journal.pone.0123570
https://doi.org/10.1371/journal.pone.0123570
Autor:
Gert R. Dohle, Katia M.C. Verhamme, Régine P.M. Steegers-Theunissen, Joop S.E. Laven, Maria A. J. de Ridder, Nicole A. Huijgen, Ann M. Vanrolleghem, Miriam C. J. M. Sturkenboom
Publikováno v:
Fertility & Sterility, 106(7), 1666-+. Elsevier Inc.
Objective To determine associations between proton-pump inhibitor (PPI) use and semen parameters in young men of couples who are planning pregnancy. Design Case-control study of a population-based registry. Setting Not applicable. Patient(s) General
Autor:
Robert A Verheij, Mirjam Kretzschmar, Marianne A B van der Sande, Johanna H K Joosten, Anita W M Suijkerbuijk, Henk J. Brouwer, Ingrid V F van den Broek, Ann M. Vanrolleghem
Publikováno v:
BMC Family Practice, 12. BioMed Central
BMC Family Practice, 12:72. BioMed Central
BMC Family Practice
Suijkerbuijk, A W M, Van Den Broek, I V F, Brouwer, H J, Vanrolleghem, A M, Joosten, J H K, Verheij, R A, van der Sande, M A B & Kretzschmar, M E E 2011, ' Usefulness of primary care electronic networks to assess the incidence of chlamydia, diagnosed by general practitioners ', BMC Family Practice, vol. 12, 72 . https://doi.org/10.1186/1471-2296-12-72
BMC Family Practice, Vol 12, Iss 1, p 72 (2011)
BMC Family Practice, 12:72. BioMed Central
BMC Family Practice
Suijkerbuijk, A W M, Van Den Broek, I V F, Brouwer, H J, Vanrolleghem, A M, Joosten, J H K, Verheij, R A, van der Sande, M A B & Kretzschmar, M E E 2011, ' Usefulness of primary care electronic networks to assess the incidence of chlamydia, diagnosed by general practitioners ', BMC Family Practice, vol. 12, 72 . https://doi.org/10.1186/1471-2296-12-72
BMC Family Practice, Vol 12, Iss 1, p 72 (2011)
Background Chlamydia is the most common curable sexually transmitted infection (STI) in the Netherlands. The majority of chlamydia diagnoses are made by general practitioners (GPs). Baseline data from primary care will facilitate the future evaluatio